Timpani Capital Management’s Amedisys AMED Stock Holding History

Timpani Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2.57M	Buy	20,817 +11,237	+117%	+$1.41M	1.23%	35
2018 Q4	$1.12M	Buy	+9,580	New	+$1.13M	0.63%	61
2017 Q3	–	Sell	-78,401	Closed	-$4.92M	–	104
2017 Q2	$4.92M	Buy	+78,401	New	+$4.57M	1.83%	8
2016 Q4	–	Sell	-47,710	Closed	-$2.26M	–	101
2016 Q3	$2.26M	Sell	47,710 -40,551	-46%	-$2.02M	0.9%	46
2016 Q2	$4.46M	Sell	88,261 -2,779	-3%	-$140K	1.89%	9
2016 Q1	$4.4M	Buy	+91,040	New	+$3.51M	1.86%	15

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Timpani Capital Management's AMED Position: Q1 2019 in Review

Timpani Capital Management increased its Amedisys (AMED) stake by 117% in Q1 2019, buying an estimated $1.41M and bringing the position to 20,817 shares worth $2.57M. The position accounts for 1.23% of the portfolio, ranked #35.

Timpani Capital Management first reported a position in AMED in Q1 2016 and has held it in 6 quarters since. The position peaked at $4.92M in Q2 2017. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

Timpani Capital Management held 20,817 shares of Amedisys worth $2.57M as of Q1 2019.
Timpani Capital Management bought 11,237 Amedisys shares in Q1 2019, an estimated $1.41M.
Amedisys made up 1.23% of Timpani Capital Management's portfolio in Q1 2019, its #35 holding.
Timpani Capital Management first reported a position in Amedisys in Q1 2016 and has held it in 6 quarters since.
Timpani Capital Management's Amedisys position peaked at $4.92M in Q2 2017.
317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on Timpani Capital Management's 13F filing for Q1 2019, filed 10 May 2019.